Technology Transfer

Active Patents

One of the main outputs of the Nanomol-bio group is the development of patents, which facilitates collaboration with companies.

The Nanomol-bio's active patents are:

- Vesicles based on glucose-derived surfactants and phytosterols
  PCT publication number: WO/2024/028283
  Priority date: 03/08/2022
  Co-owners with Nanomol Technologies SL, Spain
- Inverse OPAL hydrogel and its use
  PCT publication number: WO/2023/186794
  Priority date: 29/03/2022
- Liposomes and its use as enzyme delivery
  Priority number: EP21382062
  PCT publication number: WO/2022/161990
  Priority date: 27/01/2021
- A synthetic hydrogel and its use for immunotherapy and 3D-printing
  Priority number: EP20382432
  PCT publicaction number: WO/2021/234141
  Priority date: 21/05/2020
- Minimally-invasive continuos clinical monitoring of small molecules with analytical accuracy
  Priority number: US62/936689
  PCT publicaction number: WO/2021/100042
  Priority date: 18/11/2019
- Nanovesicles and its use for nucleic acid delivery
  PCT publicaction number: WO/2020/229469
  Priority date: 15/05/2019
- Vesicles which include epidermal growth factor and compositions that contain same
  Priority number: CU2012000112
  PCT publicaction number: WO/2014/019555
  Application date: 02/08/2012
  Licenced to Heber Biotech, Cuba
- Functionalized liposomes useful for the delivery of bioactive compounds
  Priority number: ES201231020
  PCT publicaction number: WO/2014/001509
  Priority date: 29/06/2012
- Method for obtaining micro- and nano-disperse systems
  Priority number: ES200500172
  PCT publicaction number: WO/2006/079889
  Priority date: 31/01/2005
  Exploited by Nanomol Technologies SL, Spain